DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20202185

Drug utilization study of antipsychotics among schizophrenia patients in a tertiary care teaching hospital: a retrospective observational study

Sahana M. Mogali, Basavaraj C. Kotinatot

Abstract


Background: Aim of the study was to evaluate the drug utilization pattern of antipsychotics in schizophrenia patients in a tertiary care hospital.

Methods: A retrospective observational study was conducted over a period of one year. Demographic data and drug utilization pattern of antipsychotics was collected from the surveyed prescriptions. Using WHO prescribing indicators data was analysed. Results were expressed in percentage.

Results: Out of 300 prescriptions analysed, males were 58% and females 42%. Majority of schizophrenia patients were in age group of 15 to 45 years 70.33%. Olanzapine 75% was most common antipsychotic drug prescribed followed by risperidone 10.7%. Haloperidol 9.6%, fluphenazine 3.7% and chlorpromazine 1% were the other antipsychotics prescribed. Atypical antipsychotics 85.7% were commonly prescribed than conventional ones 4.3%. Concomitant drugs prescribed were anticholinergics, antihistaminics, sedative-hypnotics, antidepressants, mood stabilizers, antiulcer drugs and vitamin B complexes. Average number of drugs prescribed per prescription 3.26.

Conclusions: Nowadays atypical antipsychotics are preferred over conventional ones because of their less side effects. Drug utilization study helps in rational usage of drugs important for patient care.


Keywords


Antipsychotics, Schizophrenia, Olanzapine

Full Text:

PDF

References


GBD 2017 Disease and injury incidence and prevalence collaborators. Global, regional and national incidence, prevalence and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;636(18):32279-7.

Schizophrenia facts and statistics. 2017. Available at: http://www.schizophrenia.com/szfacts.htm. Accessed on 4 January 2020.

Picchioni MM, Murray MR. Schizophrenia, Clinical review. BMJ. 2007;335:91-5.

Introduction to Drug Utilization Research by World Health Organization. Available at: http://www. whocc.no/filearchive/publications/drug-utilization-research.pdf. Accessed on 4 January 2020.

WHO. How to investigate drug use in health facilities: selected drug use indicators - EDM research series No. 007. 1993. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e. Accessed on 4 January 2020.

National list of Essential Medicine. 2015. Available at:http://cdsco.nic.in/WriteReadData/NLEM2015/NLEM,%202015.pdf. Accessed on 4 January 2020.

Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medicine use in Australia 2002-2007. Aust NZJ Psychiatry. 2010;44:372-7.

Chong MY, Tan CH, Fujii S, Ungyari GS, Si T, Chung EK, et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatr Clin Neurosci. 2004;58(1):61-7.

Banerjee I, Roy B, Sathian B, Banerjee I, Chakraborthy PK, Saha A. Sociodemographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal. BMC Psychiatry. 2013;13:96.

Paul PK, Konwar M, Das S. To study the prescribing pattern of antipsychotic drugs in a tertiary care hospital of Assam. Int J Pharm Pharm Sci. 2014;6(4):435-7.

Siddiqui RA, Shende TR, Mahajan HM, Borkar A. Antipsychotic medication prescribing trends in a tertiary care hospital. Int J Basic Clin Pharmacol. 2017;5(4):1417-20.

Atal S, Atal S. Drug prescribing pattern and cost analysis of antipsychotics at a tertiary care hospital. Int J Pharm Sci Res. 2016;7(6):2611-4.

Kane J. Tardive Dyskinesia: Epidemiological and Clinical Presentation. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsycho-pharmacology -5th Generation of Progress. Philadelphia, Pennsylvania: Lippincott, Williams, and Wilkins; 2002.

Buchanan RW, Kreyenbhul J, Kelley DL. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71-93.

Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 1994;48(1):25-40.

Rode SB, Ajagallay RK, Salankar HV, Sinha U. A study on drug prescribing pattern in psychiatry outpatient department from a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2014;3(3):517-22.

Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital. J Clinic Diag Res. 2013;7(12):2759-64.

George A, Chaithra S, Thomas JE, James A, Kumar ST. Study on prescribing pattern in psychiatric disorders in a tertiary care hospital. Int J Innovative Pharm Sci Res. 2016;4(6):641-7.

Patted UH, Hema NG, Nagaraj AKM. Antipsychotics in schizophrenia: a retrospective study of drug utilization pattern in outpatient department of psychiatry at a tertiary care hospital. Int J Basic Clin Pharmacol. 2018;7:167-2.